Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to spot heart transplant rejection without a biopsy

NCT ID NCT06774365

First seen May 24, 2026 · Last updated Jun 19, 2026 · Updated 6 times

Summary

This study looks at 683 heart transplant patients to see if advanced heart scans (CMR) and blood tests can detect antibody-mediated rejection, a common complication. Participants must be stable and at least one year post-transplant. The goal is to find non-invasive ways to diagnose rejection earlier and more accurately.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • ASST Grande Ospedale Metropolitano Niguarda

    RECRUITING

    Milan, Milano, 20162, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari

    NOT_YET_RECRUITING

    Bari, Bari, 70120, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Azienda Ospedaliera dei Colli

    RECRUITING

    Naples, Napoli, 80131, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    RECRUITING

    Bologna, Bologna, 40138, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better, non-invasive ways to detect rejection in heart transplant patients, reducing the need for biopsies.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may not change current practices if imaging or biomarkers prove unreliable.

Conditions

The condition(s) this trial relates to.

transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.